JP2008511637A5 - - Google Patents

Download PDF

Info

Publication number
JP2008511637A5
JP2008511637A5 JP2007530195A JP2007530195A JP2008511637A5 JP 2008511637 A5 JP2008511637 A5 JP 2008511637A5 JP 2007530195 A JP2007530195 A JP 2007530195A JP 2007530195 A JP2007530195 A JP 2007530195A JP 2008511637 A5 JP2008511637 A5 JP 2008511637A5
Authority
JP
Japan
Prior art keywords
lung
active agent
respirable
active
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530195A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008511637A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/030543 external-priority patent/WO2006026502A1/en
Publication of JP2008511637A publication Critical patent/JP2008511637A/ja
Publication of JP2008511637A5 publication Critical patent/JP2008511637A5/ja
Pending legal-status Critical Current

Links

JP2007530195A 2004-08-27 2005-08-26 致命的な感染症を治療する薬剤組成物の増強された供給 Pending JP2008511637A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60517904P 2004-08-27 2004-08-27
PCT/US2005/030543 WO2006026502A1 (en) 2004-08-27 2005-08-26 Enhanced delivery of drug compositions to treat life threatening infections

Publications (2)

Publication Number Publication Date
JP2008511637A JP2008511637A (ja) 2008-04-17
JP2008511637A5 true JP2008511637A5 (enExample) 2008-10-23

Family

ID=35520830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530195A Pending JP2008511637A (ja) 2004-08-27 2005-08-26 致命的な感染症を治療する薬剤組成物の増強された供給

Country Status (4)

Country Link
US (2) US9061027B2 (enExample)
EP (1) EP1789018A1 (enExample)
JP (1) JP2008511637A (enExample)
WO (1) WO2006026502A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
WO2008127746A1 (en) 2007-01-10 2008-10-23 Board Of Regents The University Of Texas System Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
NO2252275T3 (enExample) 2008-02-13 2018-04-28
EP2601973A1 (en) 2011-12-09 2013-06-12 Laboratoires SMB SA Dry powder formulation of azole derivative for inhalation
WO2014106727A1 (en) * 2013-01-03 2014-07-10 Vectura Limited Inhaler and formulation
WO2014186754A2 (en) 2013-05-16 2014-11-20 Board Of Regents The University Of Texas System Dry solid aluminum adjuvant-containing vaccines and related methods thereof
MX2018002586A (es) 2015-09-01 2020-11-24 First Wave Bio Inc Composiciones para usarse en el tratamiento de afecciones asociadas a una repsuesta inflamatoria anómala.
RU2766086C2 (ru) 2016-10-14 2022-02-07 Пулматрикс Оперэйтинг Компани, Инк. Противогрибковые сухие порошки
CA3083953A1 (en) 2017-12-11 2019-06-20 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
US10993890B2 (en) 2018-03-15 2021-05-04 Pelli Skin Co., Llc Antifungal solution and foot wipe
US20210145739A1 (en) * 2018-04-18 2021-05-20 Pulmatrix Operating Company, Inc. Antifungal formulations for pulmonary administration comprising itraconazole
MX2021000796A (es) * 2018-07-24 2021-06-15 Univ Texas Composiciones de partículas terapéuticamente activas con superficie modificada por congelación ultra-rápida.
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
WO2021188564A1 (en) 2020-03-16 2021-09-23 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound
CN111568878B (zh) * 2020-05-22 2022-03-25 浙江圣兆药物科技股份有限公司 一种基于液下气流喷雾技术制备多肽类药物微球的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950477A (en) 1988-08-23 1990-08-21 Memorial Hospital For Cancer And Allied Dieseas Method of preventing and treating pulmonary infection by fungi using aerosolized polyenes
GB8908250D0 (en) 1989-04-12 1989-05-24 Fisons Plc Formulations
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
EP0810853B1 (en) 1995-02-24 2004-08-25 Elan Pharma International Limited Aerosols containing nanoparticle dispersions
US5539021A (en) 1995-06-05 1996-07-23 The Dow Chemical Company Process for preparing high internal phase ratio emulsions and latexes derived thereof
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6630169B1 (en) * 1999-03-31 2003-10-07 Nektar Therapeutics Particulate delivery systems and methods of use
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
US6756062B2 (en) * 2000-11-03 2004-06-29 Board Of Regents University Of Texas System Preparation of drug particles using evaporation precipitation into aqueous solutions
AU2002245181B2 (en) * 2000-12-21 2006-06-29 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
US20040022862A1 (en) 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US20030072807A1 (en) 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
JP2004517699A (ja) 2001-01-30 2004-06-17 ボード オブ リージェンツ ユニバーシティ オブ テキサス システム 液体中への噴霧凍結によるナノ粒子およびミクロ粒子の製造方法
WO2003032951A1 (en) 2001-08-29 2003-04-24 Dow Global Technologies Inc. A process for preparing crystalline drug particles by means of precipitation
DE10145361A1 (de) * 2001-09-14 2003-04-03 Pari Gmbh Verfahren zur Herstellung von flüssigen, sterilen Zubereitungen zur Inhalation
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
CA2483218C (en) * 2002-04-25 2012-07-10 Nektar Therapeutics Uk Ltd Particulate materials
AUPS333302A0 (en) * 2002-07-02 2002-07-25 Fultec Pty Ltd A protection and indication circuit
EP1556018A1 (en) * 2002-09-30 2005-07-27 Acusphere, Inc. Sustained release porous microparticles for inhalation
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
AU2003302274A1 (en) * 2002-12-31 2004-07-29 Novartis Ag Aerosolizable pharmaceutical formulation for fungal infection therapy
JP2006513236A (ja) 2002-12-31 2006-04-20 ネクター セラピューティクス 不溶性活性物質を伴う医薬製剤
JP4933732B2 (ja) 2003-01-15 2012-05-16 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム 低温表面上で凍結させることによって得られる薬物粒子
US9192578B2 (en) 2008-08-20 2015-11-24 Board Of Regents, The University Of Texas System Hot-melt extrusion of modified release multi-particulates

Similar Documents

Publication Publication Date Title
JP6904929B2 (ja) エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用
JP7334145B2 (ja) 鼻腔内送達用乾燥粉末組成物
JP2008511637A5 (enExample)
CN105188757B (zh) 多孔载体颗粒和微粒化药物的可吸入团聚物
US20220184080A1 (en) Nebulized imatinib formulations, manufacture, and uses thereof
JP2003521459A (ja) 医薬用エーロゾル製剤
JP2002541183A (ja) 医薬用エアゾール製剤
JP2002526459A (ja) 医療用エアゾ−ル製剤
JP2002529396A (ja) 超微粒子薬剤を含んで成るエーロゾル
JP2002506017A (ja) ニコチン吸入器
JP2002527473A (ja) フォルモテロールを含む貯蔵可能な活性物質濃縮物
CN101083979A (zh) 药物制剂
AU2003273273B2 (en) Trospium containing compositions
JP2009539958A (ja) 安定なエアロゾル医薬製剤
JP2002538855A (ja) リポソーム粉末エアロゾルの肺適用のための圧縮空気吸入器及びそのために適した粉末エアロゾル
CN102905694B (zh) 吸入溶液
JP2008511637A (ja) 致命的な感染症を治療する薬剤組成物の増強された供給
JP6503043B2 (ja) 新規噴射剤含有チオトロピウム製剤
AU2019256453B2 (en) Methods of treating fungal infections
JP2013539784A (ja) 嚢胞性線維症の吸入デヌホソルでの治療方法
EP4333853A1 (en) Methods for treating a pulmonary disease with an alk-5 (tgf beta r1) inhibitor
JP5437543B2 (ja) 喘息検出用製剤
KR20220080127A (ko) 폐 질환을 위한 흡입 가능한 건조 분말 조성물
Sallam Recent advances in the formulation development of inhalational dosage forms
JP2005206485A (ja) イソキノリンスルホンアミド誘導体を含有する医薬